Article
The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors.
Endocrinology - 1 May 1998
Tagami T, Kopp P, Johnson W, Arseven O K, Jameson J L
Abstract excerpt
The thyroid hormone receptor splice variant, alpha2, is unable to bind thyroid hormone (T3) and has been proposed to function as an endogenous inhibitor of T3 action. In this report, we examined further the DNA sequence requirements for alpha2 binding to thyroid hormone response elements (TREs) in an attempt to identify response elements that mediate potent inhibition by alpha2. Heterodimers of alpha2 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
